Literature DB >> 23433963

Reduced expression of TRIF in chronic HBV infected Iranian patients.

Fatemeh Ayoobi1, Gholamhossein Hassanshahi, Nahid Zainodini, Hossein Khorramdelazad, Mohammad Kazemi Arababadi, Derek Kennedy.   

Abstract

BACKGROUND AND AIMS: TRIF is one of the main intracellular adaptor proteins required for TLR3 and 4 signaling. Abnormal gene expression of TRIF may lead to abrogated immune responses against viral infections including hepatitis B infection. The aim of this study was to identify the mRNA levels of TRIF in PBMCs isolated from chronic HBV (CHB) infected patients.
MATERIAL AND METHODS: mRNA was isolated from 63 CHB patients and 60 healthy controls and transcript levels of TRIF were examined in parallel with beta-actin (as housekeeping gene) using Real-Time PCR techniques.
RESULTS: Our results demonstrated that expression of TRIF was significantly decreased in PBMCs isolated from CHB patients when compared to healthy controls.
CONCLUSIONS: Based on the results reported here, it seems that CHB patients are unable to express appropriate levels of the TRIF gene, which may attenuate TLR3 and 4 signaling subsequent to HBV infection. Our results suggest a possible mechanism, which may explain why hepatitis B infection is stable in CHB patients.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  HBV; Hepatitis B virus; IRAK1; IRF3; Interferon regulatory transcription factor 3; Interleukin-1 receptor associated kinase-1; MYD88; NF-κB; Nuclear factor kappa-light-chain-enhancer of activated B cells; PAMP; PBMC; TIR-domain-containing adapter-inducing interferon-β; TLR; TNF receptor associated factor; TRAF6; TRIF; Toll Like Receptor; myeloid differentiation primary response; pathogen associated molecular patterns; peripheral blood mononuclear cell

Mesh:

Substances:

Year:  2013        PMID: 23433963     DOI: 10.1016/j.clinre.2012.11.005

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  6 in total

Review 1.  Innate immune targets of hepatitis B virus infection.

Authors:  Zhi-Qiang Zou; Li Wang; Kai Wang; Ji-Guang Yu
Journal:  World J Hepatol       Date:  2016-06-18

Review 2.  TLR3 plays significant roles against hepatitis B virus.

Authors:  Masoud Karimi-Googheri; Mohammad Kazemi Arababadi
Journal:  Mol Biol Rep       Date:  2014-01-30       Impact factor: 2.316

3.  Ectopic expression of micro-RNA-1, 21 and 125a in peripheral blood immune cells is associated with chronic HBV infection.

Authors:  Mohammad Momeni; Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Mol Biol Rep       Date:  2014-04-16       Impact factor: 2.316

4.  Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma.

Authors:  Jia Wen Yin; Mao Ping Huang; Bei Zhong
Journal:  Hepat Mon       Date:  2016-05-23       Impact factor: 0.660

5.  Comparison of ISG15, IL28B and USP18 mRNA levels in peripheral blood mononuclear cells of chronic hepatitis B virus infected patients and healthy individuals.

Authors:  Seyed Mohammad Ali Hashemi; Jamal Sarvari; Mohammad Reza Fattahi; Razieh Dowran; Amin Ramezani; Seyed Younes Hosseini
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

6.  Up-regulation of RIP1 and IPS-1 in chronic HBV infected patients.

Authors:  Minoo Safari-Arababadi; Mohammad Hossein Modarressi; Mohammad Kazemi Arababadi
Journal:  Genet Mol Biol       Date:  2019-08-19       Impact factor: 1.771

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.